Earnings History Data for Nautilus Biotechnology (NAUT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Nautilus Biotechnology

Nautilus Biotechnology Inc. is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus Biotechnology Inc., formerly known as Arya Sciences Acquisition Corp III, is based in SEATTLE.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-02-2024	PM		NAUT	Nautilus Biotechnology	351.00	-0.14	-0.16	0.00	Nautilus Biotechnology GAAP EPS of -$0.14 beats by $0.01 [2/28/2024 8:04 AM]	2.82	-0.12 (-4.08%)	2.96	0.02 (0.68%)	1.97 - 4.65	49,507	70,000	321
Nautilus Biotechnology GAAP EPS of -$0.14 beats by $0.01 [2/28/2024 8:04 AM] Nautilus Biotechnology files $300M mixed securities shelf [2/28/2024 3:51 PM]
31-10-2023	PM		NAUT	Nautilus Biotechnology, Inc.	90.59	-0.13	-0.18	-0.11	Nautilus Biotechnology GAAP EPS of -$0.13 misses by $0.01 [10/31/2023 9:05 AM]	2.54	0.20 (8.55%)	2.04	-0.30 (-12.82%)	1.50 - 4.65	49,868	120,000	174
Nautilus Biotechnology GAAP EPS of -$0.13 misses by $0.01 [10/31/2023 9:05 AM]
02-08-2023	PM		NAUT	Nautilus Biotechnology, Inc.	410.81	-0.13	-0.17	-0.12	Nautilus Biotechnology GAAP EPS of -$0.13 beats by $0.01 [8/2/2023 7:49 AM]	3.05	-0.10 (-3.17%)	2.90	-0.25 (-7.94%)	1.50 - 4.65	94,660	70,000	705
Nautilus Biotechnology Q2 2023 Earnings Preview [8/1/2023 1:25 PM] Nautilus Biotechnology GAAP EPS of -$0.13 beats by $0.01 [8/2/2023 7:49 AM]
02-05-2023	PM	6:05 AM ET (May 2)	NAUT	Nautilus Biotechnology, Inc.	317.16	-0.12	-0.16	-0.13	Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.03 [5/2/2023 6:38 AM]	2.27	-0.27 (-10.63%)	0.0	0.0 (0.00%)	1.50 - 5.07	114,787	60,000	0
Nautilus Biotechnology Q1 2023 Earnings Preview [5/1/2023 1:29 PM] Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.03 [5/2/2023 6:38 AM]
23-02-2023	PM	6:05 AM ET (Feb 23)	NAUT	Nautilus Biotechnology, Inc.	278.13	-0.11	-0.14	-0.13	Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03 [2/23/2023 6:07 AM]	1.85	-0.15 (-7.50%)	0.0	0.0 (0.00%)	1.50 - 5.07	78,325	80,000	0
Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03 [2/23/2023 6:07 AM]
01-11-2022	PM	6:50 AM ET (Nov 1)	NAUT	Nautilus Biotechnology, Inc.	297.95	-0.11	-0.14	-0.12	Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03 [11/1/2022 6:18 AM]	2.40	-0.07 (-2.83%)	2.54	0.07 (2.83%)	1.86 - 6.33	138,197	140,000	1,531
Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03 [11/1/2022 6:18 AM] Nautilus Biotechnology Reports Third Quarter 2022 Financial Results [Nov-01-22 06:05AM]
02-08-2022	PM	6:00 AM ET (Aug 2)	NAUT	Nautilus Biotechnology, Inc.	328.58	-0.12	-0.17	-0.19	Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.05 [8/2/2022 6:53 AM]	2.78	-0.08 (-2.80%)	2.91	0.05 (1.75%)	2.53 - 12.38	467,002	140,000	340
Nautilus Biotechnology Q2 2022 Earnings Preview [8/1/2022 1:30 PM] Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.05 [8/2/2022 6:53 AM] Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development [Aug-01-22 04:05PM]
03-05-2022	PM	6:00 AM ET (May 3)	NAUT	Nautilus Biotechnology	560.00	-0.13	-0.15	0.00	Nautilus Biotechnology Non-GAAP EPS of -$0.13 beats by $0.03 [5/3/2022 6:12 AM]	4.78	-0.06 (-1.34%)	4.65	-0.19 (-3.93%)	3.36 - 12.38	406,838	240,000	820
Nautilus Biotechnology Q1 2022 Earnings Preview [5/2/2022 12:50 PM] Nautilus Biotechnology Non-GAAP EPS of -$0.13 beats by $0.03 [5/3/2022 6:12 AM] Nautilus Biotechnology Reports First Quarter 2022 Financial Results [May-03-22 06:00AM]
24-02-2022	PM	6:00 AM ET (Feb 24)	NAUT	Nautilus Biotechnology, Inc.	454.45	-0.13	-0.15	0.00	Nautilus Biotechnology GAAP EPS of -$0.13 in-line [2/24/2022 6:04 AM]	4.15	-0.04 (0.00%)	0.0	0.0 (0.00%)	3.94 - 25.89	312,702	452,050	0
Nautilus Biotechnology Q4 2021 Earnings Preview [2/23/2022 11:15 AM] Nautilus Biotechnology GAAP EPS of -$0.13 in-line [2/24/2022 6:04 AM] Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results [Feb-24-22 06:00AM]
02-11-2021	PM	6:00 AM ET (Nov 2)	NAUT	Nautilus Biotechnology, Inc.	676.35	-0.12	-0.11	0.00	Nautilus Biotechnology reports Q3 results [11/2/2021 6:03 AM]	5.83	0.39 (7.17%)	5.83	0.0 (0.00%)	5.08 - 25.89	887,166	430,000	463
Nautilus Biotechnology reports Q3 results [11/2/2021 6:03 AM] Cowen initiates Nautilus Biotech with an outperform; shares up 10% [11/2/2021 11:31 AM] Nautilus Biotechnology Reports Third Quarter 2021 Financial Results [Nov-02-21 06:00AM] Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome [Nov-02-21 08:00AM]
10-08-2021	PM	7:00 AM ET (Aug 10)	NAUT	Nautilus Biotechnology, Inc.	927.86	-0.19	-0.09	0.00	Nautilus Biotechnology reports Q2 results [8/10/2021 6:29 AM]	7.60	-0.38 (-4.76%)	7.93	-0.05 (-0.63%)	7.28 - 25.89	594,763	3,290,000	17,496
Nautilus Biotechnology reports Q2 results [8/10/2021 6:29 AM] Nautilus Biotechnology Appoints Karl Voss, Ph.D., as Vice President of Life Sciences Research and Development [Aug-09-21 08:00AM] Nautilus Biotechnology Reports Second Quarter 2021 Financial Results [Aug-10-21 06:00AM]